Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Capital Leases (2018 - 2025)

Historic Capital Leases for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $7000.0.

  • Neurogene's Capital Leases fell 8205.13% to $7000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $7000.0, marking a year-over-year decrease of 8205.13%. This contributed to the annual value of $26000.0 for FY2024, which is 6000.0% down from last year.
  • Per Neurogene's latest filing, its Capital Leases stood at $7000.0 for Q3 2025, which was down 8205.13% from $9000.0 recorded in Q2 2025.
  • Over the past 5 years, Neurogene's Capital Leases peaked at $65000.0 during Q4 2023, and registered a low of $5000.0 during Q3 2023.
  • Moreover, its 3-year median value for Capital Leases was $17000.0 (2025), whereas its average is $26090.9.
  • As far as peak fluctuations go, Neurogene's Capital Leases soared by 78333.33% in 2024, and later plummeted by 8301.89% in 2025.
  • Neurogene's Capital Leases (Quarter) stood at $65000.0 in 2023, then tumbled by 60.0% to $26000.0 in 2024, then tumbled by 73.08% to $7000.0 in 2025.
  • Its Capital Leases was $7000.0 in Q3 2025, compared to $9000.0 in Q2 2025 and $17000.0 in Q1 2025.